The Future of Fighting Cancer

On November 3, PhRMA sponsored The Atlantic’s People v. Cancer event, hosting “PhRMA Presents: The Future of Fighting Cancer.” PhRMA’s Chief Operating Officer, Lori Reilly, joined Eli Lilly and Company’s Jacob Van Naarden, Chief Executive Officer at Loxo@Lilly, for a conversation on recent advancements in cancer research and care, as well as the potential negative impacts of the Inflation Reduction Act on cancer research and treatment development.


November 3, 2022, at 10:30 a.m. ET


  • Lori Reilly, Esq., Chief Operating Officer, PhRMA
  • Jacob Van Naarden, Executive Vice President, Eli Lilly and Company; Chief Executive Officer, Loxo@Lilly

Watch the Event Video Here